|Bid||266.24 x 800|
|Ask||278.33 x 900|
|Day's range||269.55 - 276.49|
|52-week range||206.19 - 424.00|
|Beta (5Y monthly)||1.15|
|PE ratio (TTM)||33.08|
|Earnings date||16 Feb 2023|
|Forward dividend & yield||0.76 (0.28%)|
|Ex-dividend date||24 Jan 2023|
|1y target est||284.88|
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2022 financial results before the market opens on Thursday, February 16, 2023, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
McKesson (MCK) delivered earnings and revenue surprises of 8.83% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced participation at Pharmapack Europe 2023 in Paris, France to showcase its leadership and expertise on industry challenges and trends in packaging and containment. The company expands its innovations for global customers and their patients with the introduction of three new products: West Ready Pack™ with Corning Valor® RTU Vials utilizing Stevanato Group's EZ